Acta Scientific Medical Sciences (ASMS) (ISSN: 2582-0931)

Case Report Volume 4 Issue 10

A Rare Case Report of Asymptomatic Filariasis in a Patient of Malaria

Gunvanti Rathod* and Jignasha Bhalodia

Department of Pathology, GMERS Medical College, Sola, Ahmedabad, Gujarat, India

*Corresponding Author: Gunvanti Rathod, Department of Pathology, GMERS Medical College, Sola, Ahmedabad, Gujarat, India.

Received: August 17, 2020; Published: October 14, 2020

×

Abstract

  Malaria and filaria are the two major mosquito borne public health diseases in India.Malaria is the major parasitic disease of human being with transmission in 107 countries containing three billion people each year in the world. Human lymphatic filariasis is a vector-borne disease mainly caused by the parasitic nematode Wuchereria bancrofti. In the present case report patient had coinfection of Plasmodium vivax and Wuchereria bancrofti who had shown symptoms of malaria. The purpose of this case report is to be aware about this rare coinfection so that while routine screening of haematological smears one should keep in mind about such entity. We had reported this in peripheral blood smear of patient during random screening of smear for malaria.

Keywords: Malaria; Filaria; Plasmodium vivax; Wuchereria bancrofti; Coinfection

×

References

  1. Rathod GB and Parmar P. “Study of association of thrombocytopenia with Plasmodium vivax infection”. The Indian Journal of Medical Sciences 69 (2017): 33-35.
  2. Arwa Z Al-Riyami and Murtadha Al-Khabori. “Concomitant microfilaria and malaria infection”. Blood22 (2013).
  3. VK Satyawali., et al. “Triple Co-infection of Malaria, Filaria, and Dengue: A Rare Entity”. Journal of Laboratory Physicians 2 (2014): 136-137.
  4. Wiwanitkit V. “Concurrent malaria and dengue infection: A brief summary and comment”. Asian Pacific Journal of Tropical Biomedicine 1 (2011): 326-327.
  5. Dolo H., et al. “Filariasis attenuates anemia and proinflammatory responses associated with clinical malaria: A matched prospective study in children and young adults”. PLOS Neglected Tropical Diseases 6 (2012): 1890.
  6. B Ravindran., et al. “Lymphatic filariasis and malaria: concomitant parasitism in Orissa, India”. Transactions of the Royal Society of Tropical Medicine and Hygiene1 (1998): 21-23.
  7. World Health Organization, “Lymphatic filariasis: the disease and its control,” Fifth Report of The WHO Expert Committee on Filariasis, Geneva, Switzerland (1992).
  8. S Babu and TB Nutman. “Immunopathogenesis of lymphatic filarial disease”. Seminars in Immunopathology6 (2012): 847-861.
  9. JK Baird and RC Neafie. “South American Brugian filariasis: report of a human infection acquired in Peru”. American Journal of Tropical Medicine and Hygiene2 (1988): 185-188.
  10. World Health Organization. Manual of Basic Techniques for a Health Laboratory, Geneva, Switzerland, 2nd edition (2003).
  11. World Health Organization. “Lymphatic filariasis,” Fourth report of the WHO Expert Committee on Filariasis, Geneva, Switzerland (1984).
  12. World Health Organization, Manual of Basic Techniques for a Health Laboratory, Geneva, Switzerland, 2nd edition (2003).
  13. GE Kwan-Lim., et al. “Filarial specific IgG4 responses correlates with active Wuchereria infection”. Journal of Immunology 145 (1990): 4298-4305.
  14. A Kurniawan., et al. “Differential expression of IgE and IgG4 specific antibody responses in asymptomatic and chronic human filariasis”. Journal of Immunology9 (1993): 3941-3950.
  15. GJ Weil., et al. “The ICT filariasis test: A rapid-format antigen test for diagnosis of bancroftian filariasis”. Parasitology Today10 (1997): 401-404.
  16. JS McCarthy., et al. “Evaluation of a polymerase chain reaction-based assay for diagnosis of Wuchereria bancrofti infection”. Journal of Infectious Diseases6 (1996): 1510-1514.
×

Citation

Citation: Gunvanti Rathod and Jignasha Bhalodia. “A Rare Case Report of Asymptomatic Filariasis in a Patient of Malaria". Acta Scientific Medical Sciences 4.10 (2020): 188-190



Metrics

Acceptance rate35%
Acceptance to publication20-30 days
Impact Factor1.183

Indexed In




Contact US